We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+12.36%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.45B
AUM Growth
+$91.7M
(+6.7%)
Cap. Flow
-$34M
Cap. Flow
% of AUM
-2.34%
Top 10 Holdings %
Top 10 Hldgs %
38.91%
Holding
217
New
7
Increased
36
Reduced
127
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$2.91M |
| 2 |
Medtronic
MDT
|
+$2.84M |
| 3 |
Perrigo
PRGO
|
+$2.61M |
| 4 |
Teradyne
TER
|
+$1.71M |
| 5 |
TJX Companies
TJX
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.9M |
| 2 |
NVIDIA
NVDA
|
+$3.71M |
| 3 |
Amalgamated Financial
AMAL
|
+$2.86M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.78M |
| 5 |
Analog Devices
ADI
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.94% |
| 2 | Healthcare | 25.6% |
| 3 | Industrials | 15.08% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 9.21% |
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Reynders McVeigh Capital Management held 217 positions worth $1.45B, up 6.7% from $1.36B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Reynders McVeigh Capital Management's Q1 2023 filing shows 7 new, 36 increased, 127 reduced and 14 closed positions. Its largest new stake was Perrigo: 72,303 shares worth $2.59M. The largest sale was Apple, an estimated $3.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- Reynders McVeigh Capital Management's largest Q1 2023 buy was Perrigo: 72,303 shares worth $2.59M.
- Reynders McVeigh Capital Management added most to Aptiv in Q1 2023, an estimated $2.91M increase.
- Reynders McVeigh Capital Management's biggest Q1 2023 reduction was Apple, cutting an estimated $3.9M.
- Reynders McVeigh Capital Management fully exited AstraZeneca in Q1 2023, selling an estimated $651K.
- Reynders McVeigh Capital Management's ten largest holdings make up 39% of its $1.45B portfolio in Q1 2023.
- Reynders McVeigh Capital Management opened 7 new positions and closed 14 in Q1 2023.
- Reynders McVeigh Capital Management's portfolio value rose 6.7% quarter-over-quarter to $1.45B.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2023, filed 3 May 2023.